Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alfuzosin (SL 77499) is an orally available, competitive α1-adrenoceptor antagonist.Alfuzosin induces smooth muscle relaxation in the bladder neck and prostate.Alfuzosin has been used to study benign prostatic hypertrophy, lower urinary tract symptoms (LUTS), and ejaculatory dysfunction (EjD).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 9,500 | |||
25 mg | 在庫あり | ¥ 17,000 | |||
50 mg | 在庫あり | ¥ 28,500 | |||
100 mg | 在庫あり | ¥ 45,500 | |||
500 mg | 在庫あり | ¥ 114,000 |
説明 | Alfuzosin (SL 77499) is an orally available, competitive α1-adrenoceptor antagonist.Alfuzosin induces smooth muscle relaxation in the bladder neck and prostate.Alfuzosin has been used to study benign prostatic hypertrophy, lower urinary tract symptoms (LUTS), and ejaculatory dysfunction (EjD). |
In vitro | In male Wistar rats weighing 250-450 g, Alfuzosin (10 mg/kg; oral administration; single dose) increased prostatic concentrations to 4.1-8.6 times higher than plasma concentration[1]. |
In vivo | In male Wistar rats weighing 250-450 g, Alfuzosin (10 mg/kg; oral administration; single dose) increases prostatic concentrations to 4.1-8.6 times higher than plasma concentration[1]. |
別名 | SL 77499 |
分子量 | 389.45 |
分子式 | C19H27N5O4 |
CAS No. | 81403-80-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (102.71 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alfuzosin 81403-80-7 GPCR/G Protein Neuroscience Adrenergic Receptor SL 77499 Inhibitor inhibitor inhibit